Annual Reports

Quarterly Reports


  • 8-K (Nov 8, 2013)
  • 8-K (Oct 29, 2013)
  • 8-K (Oct 22, 2013)
  • 8-K (Oct 2, 2013)
  • 8-K (Sep 27, 2013)
  • 8-K (Sep 11, 2013)


Allergan Finance LLC 8-K 2013

Documents found in this filing:

  1. 8-K
  2. 8-K
Form 8-K





Washington, D.C. 20549







Pursuant To Section 13 or 15(d)

Of the Securities and Exchange Act Of 1934

May 10, 2013

Date of Report (Date of earliest event reported)




(Exact name of registrant as specified in its charter)




Nevada   001-13305   95-3872914

(State or other Jurisdiction

of Incorporation)



File Number)


(IRS Employer

Identification Number)


Morris Corporate Center III

400 Interpace Parkway

Parsippany, New Jersey

(Address of principal executive offices)   (Zip Code)

(862) 261-7000

(Registrant’s telephone number, including area code)


(Former Name or Former Address, if Changed Since Last Report)



Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 10, 2013, Actavis, Inc. (“the Company”) held its 2013 Annual Meeting of Stockholders (the “Annual Meeting”) in Parsippany, NJ.

At the Annual Meeting, the Company’s stockholders voted on a total of four proposals, as described below.


  1. Election of Directors:

The following directors were elected to the Company’s Board of Directors for a term of one year expiring at the Annual Meeting of Stockholders in 2014, with voting results as follows:


     For      Against      Abstain      Broker Non-Votes  

Jack Michelson

     99,797,651         2,312,490         150,140         9,660,755   

Ronald R. Taylor

     99,505,830         2,603,681         150,770         9,660,755   

Andrew L. Turner

     99,775,051         2,334,434         150,796         9,660,755   

Paul M. Bisaro

     99,888,886         2,219,481         151,914         9,660,755   

Christopher W. Bodine

     101,103,018         1,006,860         150,403         9,660,755   

Michel J. Feldman

     99,411,806         2,697,197         151,278         9,660,755   

Fred G. Weiss

     99,444,555         2,666,193         149,533         9,660,755   


  2. Advisory Vote on the Compensation of Our Named Executive Officers:

The Company’s stockholders voted to approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, as such compensation was described in the Compensation Discussion and Analysis, compensation tables and narrative discussion set forth in the Company’s 2013 Proxy Statement, with voting results as follows:


For    Against    Abstain    Broker Non-Votes
98,113,946    3,618,524    527,811    9,660,755


  3. Ratification of the Appointment of PricewaterhouseCoopers LLP:

The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013, with voting results as follows:


For    Against    Abstain    Broker Non-Votes
109,421,186    2,309,674    190,176    0

  4. Stockholder Proposal for Executives to Retain a Percentage of Shares Until Retirement:

The Company’s stockholders rejected a stockholder proposal that the Company adopt a policy requiring that senior executives retain a significant percentage of shares acquired through equity pay programs until reaching normal retirement age, with voting results as follows:


For    Against    Abstain    Broker Non-Votes
42,702,917    59,271,426    285,938    9,660,755


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: May 13, 2013   ACTAVIS, INC.

/s/ David A. Buchen

    David A. Buchen
    Chief Legal Officer - Global
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki